| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.00042 | 1 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.00025 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.00021 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.00017 | 1 |